Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 3,780 shares at $86.61 ($328K) on 2021-03-04, disclosed to the SEC on 2021-03-05.
Seasonal sale ($328k) by Chief Operating Officer — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.61 | 1,828 | $158K | 48.3% |
| 2 | $86.61 | 1,828 | $158K | 48.3% |
| 3 | $89.09 | 124 | $11K | 3.4% |
| Total | $86.69 avg | 3,780 | $328K | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |